• Home
  • Contact
  • Search

Search form

  • Competences
  • Platforms
    • Antibiotics
    • Biocatalysis and Biosynthesis
    • Bioresource Technologies
    • In Vitro Diagnostics
    • Personalized Medicine
    • Single-Use-Technology
    • TEDD Tissue Engineering for DD
    • Training for Pharma/Biotech
    • Translational and Clinical Bio-Manufacturing
  • Research and Development
    • Projects
    • Working with the Network
  • Services
    • Consulting Services
    • Working with the Network
  • Organisation
    • Members
    • Associated Members
    • Advisory Council
    • Joining the network
    • History
    • Organigramm
    • Forms
  • Events/News
    • Events
    • News
      • CHIMIA 2018 No 6 - The New, Stringent MDR and IVDR Regulations: Viewing this Change as an Opportunity
    • Galleries
  • Events
  • News
    • CHIMIA 2018 No 6 - The New, Stringent MDR and IVDR Regulations: Viewing this Change as an Opportunity
  • Galleries

biotechnet newsletter

Stay informed on our latest news!

CHIMIA 2018 No 6 - The New, Stringent MDR and IVDR Regulations: Viewing this Change as an Opportunity

The healthcare and life science sector is growing inexorably and is now a multi-billion dollar industry. In 2016 the companies in this sector posted sales of USD 140 billion, and their profitability more than doubled by comparison with 2010. The pharmaceutical, diagnostics, medtech and chemical sectors have become Switzerland’s most powerful export industry and significant number of approved medications and diagnostics contain biotech elements.
 

PDF icon chimia_6-mdr_ivdr.pdf
  • Events
  • News
    • CHIMIA 2018 No 6 - The New, Stringent MDR and IVDR Regulations: Viewing this Change as an Opportunity
  • Galleries

biotechnet newsletter

Stay informed on our latest news!

© 2016 biotechnet Switzerland
  • Impressum
  • Login